Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Sales (2016 - 2025)

Sanara MedTech's Return on Sales history spans 15 years, with the latest figure at 0.02% for Q4 2025.

  • For Q4 2025, Return on Sales rose 8.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.36%, down 27.0%, while the annual FY2025 figure was 0.36%, 27.0% down from the prior year.
  • Return on Sales reached 0.02% in Q4 2025 per SMTI's latest filing, up from 1.19% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.08% in Q2 2022 to a low of 1.19% in Q3 2025.
  • Average Return on Sales over 5 years is 0.2%, with a median of 0.12% recorded in 2022.
  • Peak YoY movement for Return on Sales: increased 28bps in 2023, then tumbled -119bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.51% in 2021, then skyrocketed by 46bps to 0.27% in 2022, then surged by 95bps to 0.01% in 2023, then plummeted by -575bps to 0.1% in 2024, then skyrocketed by 82bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Return on Sales are 0.02% (Q4 2025), 1.19% (Q3 2025), and 0.07% (Q2 2025).